RESEARCH NEWS: Patient shares her experience in novel phase 1 trial for Type 1 Diabetes
We are lucky to be living in a time where technology and medical care is ever…
RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia
Centricity Research’s Chief Medical officer Dr. Ronnie Aronson shares…